- Home
- Companies
- equatorial guinea
- immunosuppression
Show results for
Refine by
Immunosuppression Suppliers Serving Equatorial Guinea
37 companies found
based inDandong , CHINA
Dandong Aolong Radiative Instrument Group Co.,Ltd. occupies 30 thousand squaremeters, and the construction area is 17 thousand square meters, owning international modern advanced manufacturing conditions and research,manufacture and test facilities. ...
based inTokyo, JAPAN
Healios will expand the possibilities for curing diseases to increase and further enrich quality of life through the development and supply of regenerative medicine products as part of the rapid progress of regenerative medicine taking place in the ...
Somatic stem cell regenerative medicine utilizes somatic stem cells, which are present in various tissues of the body, with the aim of developing new treatments for diseases for which the current standard of care may be limited or unavailable to ...
based inMarseille Cedex 9, FRANCE
Veracyte, formerly HalioDx, is a global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. Our ...
Veracyte offers a unique multiplex tissue imaging and analysis approach combining multiple technologies perfectly adapted to the comprehensive characterization of the tumor microenvironment. ...
based inBinhai, CHINA
Genobio Pharmaceutical Co., Ltd. was established in 2014 and is one of the subsidiaries of Tianjin Era Biology Technology Co., Ltd. Genobio focuses on the development of marine organisms and is committed to serving as a provider and integrator of ...
based inCuarte de Huerva (Zaragoza), SPAIN
OPERON was established 1973 as a private R&D laboratory in the field of immunochemistry. Initially, the target of the company was to satisfy the needs of the Spanish market. Three years later, the strategy changed focusing on the international ...
One-step immunochromatographic test combining two strips for the qualitative and differential detection of Respiratory Syncytial Virus (RSV) and respiratory Adenovirus, from respiratory samples such us nasopharyngeal swabs, washes and aspirates. ...
based inHunt Valley, MARYLAND (USA)
We're MedCBDx, and our focus is on making it easy to buy innovative and effective CBD products online. Our team has created two incredibly unique CBD-infused products. And, thanks to our CBD patent, we're the only manufacturer in the United States ...
based inParis, FRANCE
Enterome is pioneering the discovery and development of novel pharmaceuticals based on its unrivalled understanding of the interaction between the gut microbiome and the immune system – the Microbiome-Immunoinflammation Axis. Enterome is using this ...
based inWürzburg, GERMANY
Toleris Biotherapeutics GmbH is a biotechnology company based in Würzburg, Germany. The company specializes in the development of innovative biotherapeutic solutions aiming to advance the field of medicine through cutting-edge scientific research. ...
By leveraging optimized soluble versions of the non-classical MHC Ib molecule HLA-G, AIM Biologicals can accumulate in lymph nodes to induce regulatory CD8+ T cells that protect tissues presenting autoantigens attacked in autoimmune diseases. This ...
based inRedmond, WASHINGTON (USA)
SystImmune Inc. is a biopharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and multi-specific antibodies, as well as antibody-drug conjugates (ADCs). Our objective is to create biologics that ...
Guidance and Navigation Control (GNC) molecules are multi-specific cell engager proteins. GNC in the oncology therapeutics class bind to cancer cells and to immune cells and stimulate the immune cell cancer killing activity. By design, each GNC ...
based inRapperswil, SWITZERLAND
Neovii is an independent, global biopharmaceutical company with a patient-focused mission to develop and bring to market novel life-transforming therapies to improve the outcomes in transplantation medicine, hemato-oncological and immune disorders. ...
Organ transplantation is a lifesaving procedure for end-stage organ failure. Solid-organ transplantation involves replacing the diseased or failing organ with a new, healthy one. Commonly transplanted organs are the kidney, liver, heart, and ...
based inSint-Denijs Westrem, BELGIUM
We are a commercial stage medical device company developing the alfapump® platform for the treatment of fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. The alfapump®, is a fully ...
Liver disease, a large and growing market globally. Cirrhosis is late-stage liver disease which occurs when scar tissue (fibrosis) replaces healthy tissue. Alcohol and viral hepatitis B and C are common causes of cirrhosis, although there are many ...
based inParís, FRANCE
Biogen Technologies S.L. is a recognized leader in sustainable water hygiene solutions. Its portfolio includes a diverse range of advanced filtering systems designed for medical applications, including endpoint tap and shower filters, as well as ...
based inBerlin, GERMANY
Transplantation medicine and plastic surgery rely on artificial materials without physiologic functionality or transplants from human and animal sources that require immunosuppression. Cellbricks vision is a future where biofabrication of organs and ...
based inShanghai, CHINA
Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation immunotherapies to benefit cancer patients worldwide. Elpiscience has a robust pipeline of globally innovative cancer immunotherapies covering a wide ...
ES002’s dual ATP-adenosine mechanism is a potentially powerful TME regulator and transformative cancer immunotherapy. In preclinical studies ES002 demonstrated significant single agent anti-tumor activity as well as an excellent tolerability ...
based inOxford, UNITED KINGDOM
Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer ...
The Modi-2 vaccine exploits a second post-translational modification, stimulating the production of CD4 T cells using tumour-associated peptide epitopes in which the lysine residues are converted to homocitrulline. This change occurs via a process ...
based inSan Mateo de Gállego Zaragoza, SPAIN
CerTest Biotec, S.L. is an independent biotechnology company devoted to the development and manufacturing of IVD diagnostic products in human clinical field. An innovative technology-based company whose success lies in its human capital, highly ...
CerTest Legionella one step card test is a coloured chromatographic immunoassay for the qualitative detection of Legionella pneumophila serogroup 1 in human urine samples. CerTest Legionella card test offers a highly sensitive and simple screening ...
based inWarminster, PENNSYLVANIA (USA)
Since its founding in 1993, Varsal has grown from a small analytical instrument company to a global custom chemical and instrument manufacturing company through advanced chemical technologies, wholly-owned manufacturing facilities and world-wide ...
Other names: Chlormethine hydrochloride, Mechlorethamine HCl. Molecular weight: 192.52. Appearance: white crystalline powder. CAS#: ...
based inIpswich, UNITED KINGDOM
Safewater was founded in 1999 with the objective of introducing a safe, non-chemical product that could control Legionella. It was set up at a time when active ceramics first became available, and using this technology, the company developed a ...
based inAbingdon, UNITED KINGDOM
PsiOxus is a clinical-stage company redefining therapies for solid tumors with the goal of curing patients with cancer. Our clinically validated, systemically dosed T-SIGn® viral vector platform delivers tumor-localized production of combinations of ...
Our clinically validated T-SIGn® viral vector platform delivers multiple transgene payloads that re-program the tumor microenvironment of both primary and metastatic tumors. Our platform can integrate rationally designed synthetic agents to ...
based inCambridge, MASSACHUSETTS (USA)
Seres Therapeutics is a late-clinical stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human ...
SER-155 is an investigational, oral, rationally designed, fermented microbiome therapeutic designed to reduce the incidence of gastrointestinal infections, bacteremia, and graft versus host disease (GvHD) in immunocompromised patients, including ...